Informações:
Falhas:
ID
23041
Descrição
Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode; ODM derived from: https://clinicaltrials.gov/show/NCT00216671
Link
https://clinicaltrials.gov/show/NCT00216671
Palavras-chave
Versões (1)
- 20/06/2017 20/06/2017 -
Transferido a
20 de junho de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Schizophrenia NCT00216671
Eligibility Schizophrenia NCT00216671
- StudyEvent: Eligibility
Similar models
Eligibility Schizophrenia NCT00216671
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Schizophrenia
Item
diagnosis of schizophrenia by criteria of diagnostic and statistical manual of mental diseases, fourth edition (dsm-iv)
boolean
C0036341 (UMLS CUI [1])
Acute schizophrenic episode
Item
acute episode of schizophrenia within 2 weeks of study entry
boolean
C0813173 (UMLS CUI [1])
Study Subject untreated | Antipsychotic Agents Oral | Antipsychotic Agents Injectable Active short-term | Zuclopenthixol
Item
o subjects currently not treated or treated with oral antipsychotics or short-acting injectable antipsychotics (zuclopenthixol acutard is allowed) at doses not exceeding the registered dose
boolean
C0681850 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0040615 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0040615 (UMLS CUI [3,1])
C0086466 (UMLS CUI [3,2])
C0205177 (UMLS CUI [3,3])
C0443303 (UMLS CUI [3,4])
C0376160 (UMLS CUI [4])
C0332155 (UMLS CUI [1,2])
C0040615 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0040615 (UMLS CUI [3,1])
C0086466 (UMLS CUI [3,2])
C0205177 (UMLS CUI [3,3])
C0443303 (UMLS CUI [3,4])
C0376160 (UMLS CUI [4])
Positive and negative syndrome scale
Item
positive and negative syndrome scale (panss) score >=80
boolean
C0451383 (UMLS CUI [1])
Clinical Global Impression Questionnaire
Item
clinical global impression - severity (cgi-s) score >=5
boolean
C3639708 (UMLS CUI [1])
Axis I diagnosis | Schizophrenia
Item
dsm-iv axis i diagnosis other than schizophrenia
boolean
C0270287 (UMLS CUI [1])
C0036341 (UMLS CUI [2])
C0036341 (UMLS CUI [2])
Risperidone allergy | Risperidone Absent response to treatment
Item
known hypersensitivity or lack of response to risperidone
boolean
C0570837 (UMLS CUI [1])
C0073393 (UMLS CUI [2,1])
C0438286 (UMLS CUI [2,2])
C0073393 (UMLS CUI [2,1])
C0438286 (UMLS CUI [2,2])
Pregnancy | Breast Feeding | Gender Contraceptive methods Inadequate
Item
pregnant or nursing females, or those without adequate contraception
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0205412 (UMLS CUI [3,3])
C0006147 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0205412 (UMLS CUI [3,3])
Substance Use Disorders | Substance Dependence
Item
alcohol or drug abuse or dependence diagnosed in the last month prior to entry,
boolean
C0038586 (UMLS CUI [1])
C0038580 (UMLS CUI [2])
C0038580 (UMLS CUI [2])